News for April 2016

News Archive

New Molecule-Building Method from TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries New Molecule-Building Method from TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries

Carbon-Carbon Coupling Made Easy.Scientists at The Scripps Research Institute (TSRI) have devised a new molecule-building method that is likely to have a major impact on the pharmaceutical industry and many other chemistry-based enterprises.

New research discovers gene that causes common deafness New research discovers gene that causes common deafness

New research funded by the charity Action on Hearing Loss has taken scientists a step closer to finding a treatment for one of the most common causes of hearing loss among young adults following the discovery of a new gene which causes otosclerosis.

Scripps Florida Study Identifies Memory Suppressor Gene That Could Hold Key to New Alzheimer’s Disease Treatments Scripps Florida Study Identifies Memory Suppressor Gene That Could Hold Key to New Alzheimer’s Disease Treatments

While research has identified hundreds of genes required for normal memory formation, genes that suppress memory are of special interest because they offer insights into how the brain prioritizes and manages all of the information, including memories, that it takes in every day. These genes also provide clues for how scientists might develop new treatments for cognitive disorders such as Alzheimer’s disease.

Perfecting a Viral Pack Mule Perfecting a Viral Pack Mule

TSRI Study Shows That New Forms of a Plant Virus Are Useful in Human Therapeutics

TSRI Scientists Get First-Ever Glimpse of ‘Teenage’ HIV-Neutralizing Antibody TSRI Scientists Get First-Ever Glimpse of ‘Teenage’ HIV-Neutralizing Antibody

Scientists at The Scripps Research Institute (TSRI) and collaborating institutions have described the first-ever immature or “teenage” antibody found in a powerful class of immune molecules effective against HIV.“This is actually the first example of how we can go back to the really early stage to see how this antibody lineage was born and can develop,” said TSRI biologist Jiang Zhu, who served as co-senior author of the study.

Compulsory licences could be used more widely to prevent over pricing of drugs but they must be fair to all Compulsory licences could be used more widely to prevent over pricing of drugs but they must be fair to all

Growing concern about the rising price of drugs used in the treatment of life-limiting medical conditions is putting pressure on governments in Europe to increase their use of Compulsory Licence Orders.